FDA Inspection 1252804 — Larken Laboratories, Inc.
The FDA completed an inspection of Larken Laboratories, Inc. on October 24, 2024 in Canton, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 24, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Canton, MS (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)